HUM vs CVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

HUM

45.6
AI Score
VS
CVS Wins

CVS

49.2
AI Score

Investment Advisor Scores

HUM

46score
Recommendation
HOLD

CVS

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HUM CVS Winner
Forward P/E 26.0417 11.4286 CVS
PEG Ratio 1.344 0.2264 CVS
Revenue Growth 26.2% 7.1% HUM
Earnings Growth 27.1% 188.8% CVS
Tradestie Score 45.6/100 49.2/100 CVS
Profit Margin 0.9% 1.2% CVS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HUM 1M: +5.4% · 3M: +11.2% CVS 1M: -0.1% · 3M: -5.8%

Current Technical Phase

HUM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 63

RSI (14): 63.2 · Price: $409.80

CVS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 43

RSI (14): 43.1 · Price: $94.66

Fundamentals Snapshot

Metric HUM CVS
Market Cap
Forward P/E 24.7 11.1
Trailing P/E 37.9 25.2
Revenue (TTM)
Revenue Growth 0.3% 0.1%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.0%
EPS 10.56 3.78
Dividend Yield 0.01% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CVS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.